Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan targeted therapy for postoperative pulmonary vein stenosis after TAPVC surgery
ChiCTR2000036108Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of losartan in pulmonary vein stenosis (PVS) (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoints: Relief of pulmonary vein stenosis, Survival and 1 more. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
losartan
03
Conditions
pulmonary vein stenosis (PVS)
Beyond the preview
Go deeper on ChiCTR2000036108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036108.